HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pterygium after hyperopic laser-assisted sub-epithelial keratomileusis (LASEK).

Abstract
A 61-year-old Caucasian woman with hyperopia presented for laser refractive surgery. She had healthy eyes with the exception of a less than 0.5 mm Salzmann's nodule at 5 o'clock near the limbus of the right eye. She underwent bilateral hyperopic laser-assisted sub-epithelial keratomileusis (LASEK) combined with removal of the Salzmann's nodule. At six months, she was emmetropic with unaided vision of 6/6; however, at 10 months, she noticed a reduction of acuity in her right eye and was found to have a pterygium at 5 o'clock, encroaching 3.5 mm onto the corneal surface. She underwent excision biopsy, local application of mitomycin-C (0.2 mg/ml for two minutes) and conjunctival auto-grafting. Following surgery for the pterygium, vision returned to 6/6 unaided but six months later, there was limited recurrence (1.5 mm) of the pterygium reducing unaided vision to 6/9, due to the induction of astigmatism of -1.25 dioptres. This has remained stable for 14 months. Pterygium growth may be associated with surface excimer laser surgery and the presence of peripheral Salzmann's nodules might be a risk factor.
AuthorsDavid P S O'Brart, Katherine Williams
JournalClinical & experimental optometry (Clin Exp Optom) Vol. 96 Issue 3 Pg. 336-8 (May 2013) ISSN: 1444-0938 [Electronic] United States
PMID22775539 (Publication Type: Case Reports, Journal Article)
Copyright© 2012 The Authors; Clinical and Experimental Optometry © 2012 Optometrists Association Australia.
Topics
  • Female
  • Humans
  • Keratectomy, Subepithelial, Laser-Assisted (adverse effects)
  • Middle Aged
  • Pterygium (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: